UK markets closed

Nevro Corp. (NVRO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
14.43+0.01 (+0.03%)
As of 02:40PM EDT. Market open.

Nevro Corp.

1800 Bridge Parkway
Redwood City, CA 94065
United States
650 251 0005
https://nevro.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees1,215

Key executives

NameTitlePayExercisedYear born
Mr. Roderick H. MacLeodSenior VP & CFO729.61kN/A1967
Mr. Kashif RashidSenior VP, General Counsel & Corporate Secretary703.35kN/A1974
Mr. Kevin R. ThornalPresident, CEO & DirectorN/AN/A1974
Mr. Richard B. CarterChief Accounting OfficerN/AN/A1971
Mr. Christofer ChristoforouSenior Vice President of Technical Operations367.4kN/A1970
Geeta KavetiVP and Chief Compliance & Privacy OfficerN/AN/AN/A
Mr. Jon R. ShearSenior Vice President of Corporate DevelopmentN/AN/AN/A
Meredith VornholtVice President of Global MarketingN/AN/AN/A
Ms. Shana D. Ross M.B.A.Senior VP & Chief of Human Resources OfficerN/AN/AN/A
Dr. David Caraway M.D., Ph.D.Senior VP & Chief Medical OfficerN/AN/A1957
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

Corporate governance

Nevro Corp.’s ISS governance QualityScore as of 1 March 2024 is 8. The pillar scores are Audit: 6; Board: 7; Shareholder rights: 4; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.